Literature DB >> 2022083

Angiotensin II receptor subtypes in rat brain.

K Song1, A M Allen, G Paxinos, F A Mendelsohn.   

Abstract

1. Angiotensin II (AII) receptor binding was localized in the rat brain by in vitro autoradiography using the antagonist analogue, 125I-[Sar1, Ile8] AII. AII receptor binding was then differentiated into type I and type II subtypes by displacement with unlabelled non-peptide antagonists specific for AII subtypes. 2. Type I binding was determined as that inhibited by Dup753 (10 mumol/L) and type II binding as that inhibited by XD329-1 (10 mumol/L). The reducing agent dithiothreitol (DTT) decreased the binding to type I receptors and enhanced the binding to type II receptors. 3. Structures such as the vascular organ of the lamina terminalis, subfornical organ, median preoptic nucleus, area postrema, nucleus of the solitary tract, which are known to be related to some central actions of AII, contain exclusively type I AII receptors. 4. In contrast, the locus coeruleus, ventral and dorsal parts of lateral septum, superior colliculus, subthalamic nucleus, some nuclei of the thalamus, and the nuclei of the inferior olive contain predominantly type II AII receptors. 5. These results reveal important pharmacological heterogeneity of brain AII receptors which suggest different regional functions and are relevant to the central actions of emerging classes of new non-peptide AII receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022083     DOI: 10.1111/j.1440-1681.1991.tb01414.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  11 in total

1.  Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.

Authors:  R P Dennes; J C Barnes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development.

Authors:  M A Millan; D M Jacobowitz; G Aguilera; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia.

Authors:  Megan E Bardgett; John J McCarthy; Sean D Stocker
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

4.  The anteroventral third ventricle region is critical for the behavioral desensitization caused by repeated injections of angiotensin II.

Authors:  Peter J Vento; Derek Daniels
Journal:  Behav Brain Res       Date:  2013-10-18       Impact factor: 3.332

5.  Access of peripherally administered DuP 753 to rat brain angiotensin II receptors.

Authors:  K F Song; J L Zhuo; F A Mendelsohn
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

6.  Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?

Authors:  Nicole Gallo-Payet; Marie-Odile Guimond; Lyne Bilodeau; Charlotta Wallinder; Mathias Alterman; Anders Hallberg
Journal:  Front Endocrinol (Lausanne)       Date:  2011-08-26       Impact factor: 5.555

7.  Distribution of non-AT1, non-AT2 binding of 125I-sarcosine1, isoleucine8 angiotensin II in neurolysin knockout mouse brains.

Authors:  Robert C Speth; Eduardo J Carrera; Catalina Bretón; Andrea Linares; Luz Gonzalez-Reiley; Jamala D Swindle; Kira L Santos; Ines Schadock; Michael Bader; Vardan T Karamyan
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

8.  Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary.

Authors:  Courtney Premer; Courtney Lamondin; Ann Mitzey; Robert C Speth; Mark S Brownfield
Journal:  Int J Hypertens       Date:  2013-03-19       Impact factor: 2.420

9.  The Angiotensin II Type 2 Receptor in Brain Functions: An Update.

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Int J Hypertens       Date:  2012-12-25       Impact factor: 2.420

Review 10.  Targeting Renin-Angiotensin System Against Alzheimer's Disease.

Authors:  Abadi Kahsu Gebre; Birhanetensay Masresha Altaye; Tesfay Mehari Atey; Kald Beshir Tuem; Derbew Fikadu Berhe
Journal:  Front Pharmacol       Date:  2018-04-30       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.